Intracerebroventricular Pain Treatment with Analgesic Mixtures including Ziconotide for Intractable Pain.
暂无分享,去创建一个
[1] M. Schmelz,et al. Local anesthetics take a central action in analgesia. , 2015, Pain.
[2] D. Dupoiron,et al. Rationale for Prospective Assays of Intrathecal Mixtures Including Morphine, Ropivacaine and Ziconotide: Prevention of Adverse Events and Feasibility in Clinical Practice. , 2015, Pain physician.
[3] Darrin J. Lee,et al. Intracerebroventricular opiate infusion for refractory head and facial pain. , 2014, World journal of clinical cases.
[4] Blair H. Smith,et al. Neuropathic pain in the general population: A systematic review of epidemiological studies , 2014, PAIN®.
[5] T. Deer,et al. Ziconotide: a clinical update and pharmacologic review , 2013 .
[6] T. Yaksh,et al. Pharmacokinetic Analysis of Ziconotide (SNX‐111), an Intrathecal N‐Type Calcium Channel Blocking Analgesic, Delivered by Bolus and Infusion in the Dog , 2012, Neuromodulation : journal of the International Neuromodulation Society.
[7] M. Saulino,et al. Polyanalgesic Consensus Conference 2012: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel , 2012, Neuromodulation : journal of the International Neuromodulation Society.
[8] R. Raffa,et al. Intracerebroventricular opioids for intractable pain. , 2012, British journal of clinical pharmacology.
[9] M. Giglio,et al. Intrathecal combination of ziconotide and morphine for refractory cancer pain: A rapidly acting and effective choice , 2012, PAIN.
[10] D. Monnin,et al. Ziconotide adverse events in patients with cancer pain: a multicenter observational study of a slow titration, multidrug protocol. , 2011, Pain physician.
[11] T. Jensen,et al. Central poststroke pain: A population-based study , 2011, PAIN®.
[12] T. Deer,et al. Ziconotide Combination Intrathecal Therapy: Rationale and Evidence , 2010, The Clinical journal of pain.
[13] Jörn Lötsch,et al. Ziconotide for treatment of severe chronic pain , 2010, The Lancet.
[14] T. Soong,et al. Nuclear localization of Cav2.2 and its distribution in the mouse central nervous system, and changes in the hippocampus during and after pilocarpine‐induced status epilepticus , 2010, Neuropathology and applied neurobiology.
[15] C. Benedetti,et al. Intracerebroventricular Morphine for Refractory Cancer Pain: Transitioning to the Home Setting , 2010, The American journal of hospice & palliative care.
[16] C. Bernards,et al. Cerebrospinal Fluid and Spinal Cord Distribution of Hyperbaric Bupivacaine and Baclofen during Slow Intrathecal Infusion in Pigs , 2010, Anesthesiology.
[17] L. García-Larrea,et al. Imagerie des réecepteurs opioїdes chez l’homme , 2009 .
[18] G. Varrassi,et al. Intrathecal Therapy: What Has Changed With the Introduction of Ziconotide , 2009, Pain practice : the official journal of World Institute of Pain.
[19] A. Burton,et al. Intrathecal Ziconotide for Neuropathic Pain: A Review , 2009, Pain practice : the official journal of World Institute of Pain.
[20] F. De Conno,et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] T. Deer,et al. Intrathecal ziconotide and opioid combination therapy for noncancer pain: an observational study. , 2009, Pain physician.
[22] L. Webster,et al. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain. , 2008, Pain medicine.
[23] P. Staats,et al. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain. , 2008, Pain medicine.
[24] M. Wallace. Ziconotide: a new nonopioid intrathecal analgesic for the treatment of chronic pain , 2006, Expert review of neurotherapeutics.
[25] C. Bernards. Cerebrospinal Fluid and Spinal Cord Distribution of Baclofen and Bupivacaine during Slow Intrathecal Infusion in Pigs , 2006, Anesthesiology.
[26] L. Webster,et al. A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. , 2006, Journal of pain and symptom management.
[27] Hans-Georg Buchholz,et al. High opiate receptor binding potential in the human lateral pain system , 2006, NeuroImage.
[28] D. Wermeling,et al. Ziconotide, an Intrathecally Administered N‐Type Calcium Channel Antagonist for the Treatment of Chronic Pain , 2005, Pharmacotherapy.
[29] Frode Willoch,et al. Central poststroke pain and reduced opioid receptor binding within pain processing circuitries: a [11C]diprenorphine PET study , 2004, Pain.
[30] P. Navarra,et al. Electrophysiological and molecular evidence of L‐(Cav1), N‐ (Cav2.2), and R‐ (Cav2.3) type Ca2+ channels in rat cortical astrocytes , 2004, Glia.
[31] Y. Matsuda,et al. Effects of ablation of N- and R-type Ca2+ channels on pain transmission , 2002, Neuroscience Research.
[32] L. Radbruch,et al. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology , 2001, Pain.
[33] R. Penn,et al. Adverse effects associated with the intrathecal administration of ziconotide , 2000, Pain.
[34] R. Miguel,et al. Interventional treatment of cancer pain: the fourth step in the World Health Organization analgesic ladder? , 2000, Cancer control : journal of the Moffitt Cancer Center.
[35] P. Staats,et al. Intrathecal drug therapy for chronic pain: from basic science to clinical practice. , 1999, Anesthesiology.
[36] B Conrad,et al. Central pain after pontine infarction is associated with changes in opioid receptor binding: a PET study with 11C-diprenorphine. , 1999, AJNR. American journal of neuroradiology.
[37] G. Fountzilas,et al. Intraventricular administration of morphine for control of intractable cancer pain in 90 patients. , 1996, Neurosurgery.
[38] F. Mosteller,et al. Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer. , 2013, The Cochrane database of systematic reviews.
[39] I. Curelaru,et al. Continuous Intracisternal and High Cervical Intrathecal Bupivacaine Analgesia in Refractory Head and Neck Pain , 1996, Anesthesiology.
[40] T. Cramond,et al. Intraventricular Morphine for Intractable Pain of Advanced Cancer , 1994 .
[41] J. Guieu,et al. Intracerebroventricular morphine, analgesia, and nociceptive spinal reflexes , 1994, The Lancet.
[42] R. Candrina,et al. Intraventricular octreotide for cancer pain. , 1992, Journal of neurosurgery.
[43] S. L. Lu,et al. Clinical application of a patient-controlled apparatus for ventricular administration of morphine in intractable pain: report of 28 cases. , 1991, Neurosurgery.
[44] M. Debray,et al. Morphine pharmacokinetics and pain assessment after intracerebroventricular administration in patients with terminal cancer , 1991, Clinical pharmacology and therapeutics.
[45] J. G. Todd,et al. Intraventricular diamorphine via an Ommaya shunt for intractable cancer pain. , 1990, British journal of anaesthesia.
[46] T. Lee,et al. Intraventricular morphine for intractable craniofacial pain. , 1990, Singapore medical journal.
[47] R. Dewitty,et al. Long-term intraventricular infusion of morphine for intractable pain in cancer of the head and neck. , 1990, Neurosurgery.
[48] Y. Ha,et al. Intraventricular or epidural injection of morphine for severe pain , 1989, Neurochirurgia.
[49] F. Meyers,et al. Intraventricular morphine administered by hospice nurses to a patient with intractable pain , 1989, The American journal of hospice care.
[50] Y. Lazorthes. Intracerebroventricular Administration of Morphine for Control of Irreducible Cancer Pain , 1988, Annals of the New York Academy of Sciences.
[51] Victor W. Pike,et al. Regional cerebral opioid receptor studies with [11C]diprenorphine in normal volunteers , 1988, Journal of Neuroscience Methods.
[52] C. Su,et al. Intraventricular morphine produces pain relief, hypothermia, hyperglycaemia and increased prolactin and growth hormone levels in patients with cancer pain , 1987, Journal of Neurology.
[53] P. Hole,et al. [Management of pain in cancer patients by intraventricular administration of morphine]. , 1987, Ugeskrift for laeger.
[54] R. Lobato,et al. Intraventricular morphine for intractable cancer pain: rationale, methods, clinical results , 1987, Acta anaesthesiologica Scandinavica. Supplementum.
[55] A. Caraceni,et al. A validation study of the WHO method for cancer pain relief , 1987, Cancer.
[56] M. Leavens,et al. Intraventricular morphine administration for control of chronic cancer pain , 1987, Pain.
[57] F. Rychlicki,et al. [Epidural and intraventricular morphine therapy in the treatment of cancer pain]. , 1986, Minerva anestesiologica.
[58] G. Nurchi. Use of intraventricular and intrathecal morphine in intractable pain associated with cancer. , 1985, Neurosurgery.
[59] G. Marini,et al. Intraventricular morphine in paraneoplastic painful syndrome of the cervicofacial region: experience in thirty-eight cases. , 1985, Neurosurgery.
[60] P. Frérebeau,et al. Intraventricular administration of morphine in patients with neoplastic intractable pain. , 1984, Surgical neurology.
[61] R. Lobato,et al. Intraventricular morphine for control of pain in terminal cancer patients. , 1983, Journal of neurosurgery.
[62] J. Weston,et al. Intrathecal and intraventricular morphine for pain in cancer patients: initial study. , 1983, Journal of neurosurgery.
[63] M. Kuhar,et al. Autoradiographic localization of opiate receptors in rat brain. II. The brain stem , 1977, Brain Research.
[64] M. Kuhar,et al. Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla , 1977, Brain Research.
[65] S. Snyder,et al. Regional Distribution of Opiate Receptor Binding in Monkey and Human Brain , 1973, Nature.
[66] A. Ommaya. Subcutaneous reservoir and pump for sterile access to ventricular cerebrospinal fluid. , 1963, Lancet.
[67] S. Abram. Intrathecal combination of ziconotide and morphine for refractory cancer pain: A rapidly acting and effective choice , 2012 .
[68] M. Smith,et al. Cerebrospinal fluid and plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in patients before and after initiation of intracerebroventricular morphine for cancer pain management. , 1999, Anesthesia and analgesia.
[69] F. Alesch,et al. [Intraventricular morphine administration as a treatment possibility for patients with intractable pain]. , 1996, Wiener klinische Wochenschrift.
[70] P. Ince,et al. Distribution of alpha 1A, alpha 1B and alpha 1E voltage-dependent calcium channel subunits in the human hippocampus and parahippocampal gyrus. , 1996, Neuroscience.
[71] F. Bonnet,et al. [Cephalic cancer pain controlled by intraventricular administration of morphine and clonidine]. , 1995, Annales francaises d'anesthesie et de reanimation.
[72] J. Hell,et al. Biochemical properties and subcellular distribution of an N-type calcium channel alpha 1 subunit. , 1992, Neuron.
[73] J. Opavský,et al. Intracerebroventricular application of morphine in the treatment of intractable malignant pain. , 1990, Acta Universitatis Palackianae Olomucensis Facultatis Medicae.
[74] S. Blond,et al. [Intracerebroventricular morphine therapy. Apropos of 79 patients]. , 1989, Neuro-chirurgie.
[75] Y. Lazorthes,et al. Intracerebroventricular morphinotherapy for control of chronic cancer pain. , 1988, Progress in brain research.
[76] R. Franco-Bourland,et al. Intraventricular somatostatin-14, arginine vasopressin, and oxytocin: analgesic effect in a patient with intractable cancer pain. , 1987, Applied neurophysiology.
[77] F. Mundinger,et al. Continuous intraventricular morphine- or peptide-infusion for intractable cancer pain. , 1987, Acta neurochirurgica. Supplementum.
[78] R. Badenes,et al. [Intraventricular administration of morphine in the treatment of pain of neoplastic origin. Cooperative study]. , 1986, Revista espanola de anestesiologia y reanimacion.
[79] Y. Lazorthes,et al. Spinal versus intraventricular chronic opiate administration with implantable drug delivery devices for cancer pain. , 1985, Applied neurophysiology.
[80] C. Batier,et al. [Value of intraventricular morphine analgesia in intractable neoplasm pain. Apropos of 8 cases with self-administration in 4]. , 1983, Neuro-chirurgie.